Concepedia

Author

Chetan Rathi

University of Tennessee Health Science CenterORCID

Also Known As

Chetan D Rathi, Chetan Rathi, Meghraj Ingle

55

Publications

854

Citations

15

H-Index

71

Concepts

All Affiliations

University of Tennessee Health Science CenterLokmanya Tilak Municipal General Hospital and Lokmanya Tilak Municipal Medical CollegeSt. Jude Children's Research HospitalColorado State UniversityHoly Family Hospital
CR

About

Chetan Rathi is an author at University of Tennessee Health Science Center specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

12

421

2

Public Health

3

3

36

3

Biochemistry

3

3

58

4

Natural Sciences

1

1

17

5

Allergy

1

1

22

Chetan Rathi

×

19

Publications

648

Citations

14

H-Index

YearCitations

Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux

Richard Lee, Julian G. Hurdle, Jiuyu Liu,

Nature Medicine

2014

192

The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 Patients

Harshad Devarbhavi, Tarun Joseph, Nanjegowda Sunil Kumar,

Journal of Clinical and Experimental Hepatology

2020

76

Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors

Anthony B. El-Khoueiry, James S. Clarke, Tobias Neff,

British Journal of Cancer

2023

64

Drug Induced Liver Injury at a Tertiary Hospital in India: Etiology, Clinical Features and Predictors of Mortality

Chetan Rathi, Nirav Pipaliya, Ruchir Patel,

Annals of Hepatology

2017

59

Effect of Ethanol on the Metabolic Characteristics of HIV-1 Integrase Inhibitor Elvitegravir and Elvitegravir/Cobicistat with CYP3A: An Analysis Using a Newly Developed LC-MS/MS Method

Narasimha M. Midde, Mohammad Arifur Rahman, Chetan Rathi,

PLoS ONE

2016

31

Population pharmacokinetics of belantamab mafodotin, a BCMA‐targeting agent in patients with relapsed/refractory multiple myeloma

Chetan Rathi, Jon Collins, Herbert Struemper,

CPT Pharmacometrics & Systems Pharmacology

2021

25

Model-Based Exposure-Response Assessment for Spectinamide 1810 in a Mouse Model of Tuberculosis

Santosh Wagh, Chetan Rathi, Pradeep B. Lukka,

Antimicrobial Agents and Chemotherapy

2021

24

Comparative pharmacokinetics of spectinamide 1599 after subcutaneous and intrapulmonary aerosol administration in mice

Chetan Rathi, Pradeep B. Lukka, Santosh Wagh,

Tuberculosis

2018

22

Exposure–Response Analyses for Therapeutic Dose Selection of Belantamab Mafodotin in Patients With Relapsed/Refractory Multiple Myeloma

Geraldine Ferron‐Brady, Chetan Rathi, Jon Collins,

Clinical Pharmacology & Therapeutics

2021

22

Aminomethyl spectinomycins as therapeutics for drug-resistant respiratory tract and sexually transmitted bacterial infections

David F. Bruhn, Samanthi L. Waidyarachchi, Dora B. Madhura,

Science Translational Medicine

2015

19

Page 1